BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33915880)

  • 1. The
    Angus L; Starmans MPA; Rajicic A; Odink AE; Jalving M; Niessen WJ; Visser JJ; Sleijfer S; Klein S; van der Veldt AAM
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33915880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
    Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Montesinos-Rongen M; Brunn A; Deckert M; Wendl C; Dietmaier W; Goldbrunner R; Ruge MI; Mauch C; Schmidt NO; Proescholdt M; Grau S; Lohmann P
    Neuro Oncol; 2022 Aug; 24(8):1331-1340. PubMed ID: 34935978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual biopsy using MRI radiomics for prediction of BRAF status in melanoma brain metastasis.
    Shofty B; Artzi M; Shtrozberg S; Fanizzi C; DiMeco F; Haim O; Peleg Hason S; Ram Z; Bashat DB; Grossman R
    Sci Rep; 2020 Apr; 10(1):6623. PubMed ID: 32313236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma.
    Li W; Li Y; Liu X; Wang L; Chen W; Qian X; Zheng X; Chen J; Liu Y; Lin L
    Front Immunol; 2023; 14():1180908. PubMed ID: 37646022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma.
    Saadani H; van der Hiel B; Aalbersberg EA; Zavrakidis I; Haanen JBAG; Hoekstra OS; Boellaard R; Stokkel MPM
    J Nucl Med; 2019 Nov; 60(11):1545-1552. PubMed ID: 31481581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
    Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
    Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
    Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
    Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Prediction of BRAF Mutation Status in Colorectal Cancer Using a Clinical-radiomics Model.
    Xue T; Peng H; Chen Q; Li M; Duan S; Feng F
    Acad Radiol; 2022 Sep; 29(9):1298-1307. PubMed ID: 35033450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics features based on MRI predict BRAF V600E mutation in pediatric low-grade gliomas: A non-invasive method for molecular diagnosis.
    Xu J; Lai M; Li S; Ye K; Li L; Hu Q; Ai R; Zhou J; Li J; Zhen J; Cai L; Shi C
    Clin Neurol Neurosurg; 2022 Nov; 222():107478. PubMed ID: 36244075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography-based radiomics nomogram for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer: a double-center study.
    Li M; Xu G; Zhou H; Chen Q; Fan Q; Shi J; Duan S; Cui Y; Feng F
    Br J Radiol; 2023 Aug; 96(1148):20230019. PubMed ID: 37195006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapy.
    Hannan EJ; O'Leary DP; MacNally SP; Kay EW; Farrell MA; Morris PG; Power CP; Hill ADK
    Medicine (Baltimore); 2017 Dec; 96(48):e8404. PubMed ID: 29310328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics of Pediatric Low-Grade Gliomas: Toward a Pretherapeutic Differentiation of
    Wagner MW; Hainc N; Khalvati F; Namdar K; Figueiredo L; Sheng M; Laughlin S; Shroff MM; Bouffet E; Tabori U; Hawkins C; Yeom KW; Ertl-Wagner BB
    AJNR Am J Neuroradiol; 2021 Apr; 42(4):759-765. PubMed ID: 33574103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenib.
    Robinson SD; O'Shaughnessy JA; Cowey CL; Konduri K
    Lung Cancer; 2014 Aug; 85(2):326-30. PubMed ID: 24888229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.
    Shi R; Chen W; Yang B; Qu J; Cheng Y; Zhu Z; Gao Y; Wang Q; Liu Y; Li Z; Qu X
    Am J Cancer Res; 2020; 10(12):4513-4526. PubMed ID: 33415015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.
    Birner P; Berghoff AS; Dinhof C; Pirker C; Capper D; Schoppmann SF; Petzelbauer P; von Deimling A; Berger W; Preusser M
    Arch Dermatol Res; 2014 Dec; 306(10):873-84. PubMed ID: 25073704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Texture Features in Advanced Colorectal Cancer: Correlation with
    Negreros-Osuna AA; Parakh A; Corcoran RB; Pourvaziri A; Kambadakone A; Ryan DP; Sahani DV
    Radiol Imaging Cancer; 2020 Sep; 2(5):e190084. PubMed ID: 33778733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of radiomics based on
    Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The \textit{BRAF} V600E mutation in single- institution study of Russian melanoma patients.
    Lyubchenko L; Emelyanova M; Shamanin V; Demidov L; Zasedatelev A; Nasedkina T
    Cancer Biomark; 2016; 16(1):153-60. PubMed ID: 26600396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.